🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
This study is a Phase 1b/2 multi-center study to assess the safety, tolerab...
Status
Terminated
Location
Seoul National University Bundang Hospital
Start Date
2020-06-22
Trial ID
NCT04492033
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Objective: To study the influence of metabolic factors on the action of pro...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-10
Trial ID
NCT05062135
Treatments Being Tested
A growing amount of reports has consistently evidenced that a sustained inh...
Status
Completed
Location
Azienda Ospedaliero Universitaria Pisana
Start Date
2015-11
Trial ID
NCT02623621
Treatments Being Tested
This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-11-15
Trial ID
NCT00619424
Treatments Being Tested
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-19
Trial ID
NCT02581891
This study is a prospective Bayesian adaptive randomized phase II clinical ...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
Start Date
2025-01-01
Trial ID
NCT06936046
Treatments Being Tested